Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Clinical trial NCT05191017 · WITHDRAWN

Trial details

NCT number: NCT05191017
Sponsor: Nuvation Bio Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostatic Cancer Cancer of Prostate Cancer of the Prostate Prostate Neoplasm Castrate Resistant Prostate Cancer Castration Resistant Prostatic Cancer Castration Resistant Prostatic Neoplasms

Start date: 2022-09-01
Primary completion: 2025-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.